Summary: The Centers for Disease Control and Prevention (CDC) is issuing this Health Alert Network (HAN) Health Advisory to inform public health officials, clinicians, and affected patients, their families, and caregivers about potential disrupted access to care among individuals taking prescription stimulant medications and possible increased risks for injury and overdose. On June 13, 2024, the U.S. Department of Justice announced a federal health care fraud indictment against a large subscription-based telehealth company that provides attention-deficit/hyperactivity disorder (ADHD) treatment to patients ages 18 years and older across the United States. Patients who rely on prescription stimulant medications to treat their ADHD and have been using this or other similar subscription-based telehealth platforms could experience a disruption to their treatment and disrupted access to care. A disruption involving this large telehealth company could impact as many as 30,000 to 50,000 patients ages 18 years and older across all 50 U.S. states.

The founder and head doctor of telehealth company Done Global were arrested and charged with fraud, accused by federal authorities of conspiring to provide easy access to Adderall and other stimulants.

In the first three months of 2024, there were 323 active drug shortages, the highest number since 2001, according to research by the University of Utah Drug Information Service.

Individuals diagnosed with childhood attention-deficit/hyperactivity disorder (ADHD) have a higher likelihood of experiencing both cyberbullying and traditional bullying during adolescence, according to study findings published in the Journal of Adolescent Health.

A research team from the URV's Nutrition and Mental Health group has studied the prevalence of autistic spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) in schoolchildren in the Tarragona region. The research, which also determined the extent to which these disorders affect children's social relationships, collected data on 7,000 pupils, of whom 700 were studied in detail.

Autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) have more disorder-specific brain activations than shared activations, according to findings from a systematic review and meta-analysis published in the American Journal of Psychiatry.

Opioid overdoses for pregnant patients are at an all-time high in the United States, even as overall numbers are improving. Attention deficit hyperactivity disorder (ADHD) is highly correlated with substance use disorders, yet treatment protocols to help expecting parents manage opioid use disorders and ADHD together are essentially nonexistent.

Building upon the discussion of a complex case of a patient with narcolepsy, the panel provides clinical insights on cotreatment practices.

There is a high prevalence of attention deficit hyperactivity disorder (ADHD) among PA students, according to study results presented at the American Academy of Physician Associates (AAPA 2024) annual meeting, held from May 18 to 22, 2024, in Houston, Texas.

Being recently diagnosed with attention deficit hyperactivity disorder (ADHD) at the age of 34 was an eye-opening experience for me. Suddenly I realised that personality characteristics and behaviours I’d always hated and considered to be self-limiting were signs and symptoms of the disorder rather than a character flaw.

KEY POINTS: Having ADHD in your relationship can complicate thinking about leaving. Asking yourself specific questions can help illuminate your choices. Consider your contribution to the relationship problems before deciding to leave.

KEY POINTS: Rejection sensitive dysphoria is a stronger-than-expected reaction to rejection often experienced by ADHDers. For people with ADHD, there may be a neurological mechanism underlying rejection sensitivity. Young adults with ADHD may need extra support as they enter the dating scene where rejection is significant.